8-K

Company

Aclaris Therapeutics, Inc.

Filed

April 4, 2019

Period of Report

April 4, 2019

Accession Number

0001558370-19-002790

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →